The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMS 2022 | Impact of pysiotherapist-led exercise prehabilitation before and during autoHSCT in multiple myeloma
Orla McCourt, MSc, MCSP, University College London NHS Foundation Trust, London, UK, discusses the results of a study evaluating the impact of physiotherapist-led exercise prehabilitation before and during treatment with autologous hematopoietic stem cell transplantation (autoHSCT) in patients with multiple myeloma. The study reported an improvement in cancer-related fatigue and quality of life (QoL), and highlighted the need for assessing objective measures of function to identify frail patients and improve their function pre-treatment with physiotherapy. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
